The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ABVX FINANCIAL STATEMENTS

Abivax SA American Depositary Shares — balance sheet, income statement and cash flow trends

ABVXAbivax SA American Depositary Shares

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-300 M-200 M-100 M02020202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue0 €Operating Income-56.2 M € · -Infinity%Pre-tax Income-48.2 M € · -Infinity%Net Income to Owners-48.5 M € · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 €-100.0%
Gross Profit——
Operating Income-56.2 M €—
EBITDA——
Net Income to Owners-48.5 M €—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M2020202120222023202420252026

Capital Structure

Q1 2026
Total Assets547.1 M
  • Equity429.6 M €79%
  • Current Liabilities62.2 M €11%
  • Long-term Liabilities55.3 M €10%

Key Figures

YoY change
Total Assets547.1 M €+67.3%
Total Liabilities117.5 M €-10.3%
Total Equity429.6 M €+119.2%
Cash & ST Investments——
Total Debt——
Net Debt——

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M02020202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
-40 M-20 M0-50.5 M €Operating73 K €Financing-50.4 M €Net Change

Key Figures

YoY change
Operating Cash Flow-50.5 M €—
Capital Expenditures54 K €-79.6%
Free Cash Flow-50.6 M €—
Dividends Paid0 €—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ABVX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Aug 28, 26. This content is for informational purposes only and is not investment advice.